RecruitingNCT06504511

SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom


Sponsor

NHS Greater Glasgow and Clyde

Enrollment

400 participants

Start Date

Nov 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The aims of this prospective natural history study are to define the seizure, neuro-developmental, and behavioural characteristics of SCN1A-related epilepsies/Dravet syndrome in children and adults longitudinally over a period of three years. In addition, this study will compare missense and truncating genotypes in terms of i) rates of change of countable convulsive seizures per month and ii) neurodevelopmental outcome and trajectories.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with dravet syndrome, epilepsy, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Royal Hospital for Children

Glasgow, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06504511


Related Trials